These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2025335)

  • 1. A model for cholesterol reduction in a corporate research setting.
    Haselhorst BL
    AAOHN J; 1991 May; 39(5):241-8. PubMed ID: 2025335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease.
    Matson Koffman DM; Goetzel RZ; Anwuri VV; Shore KK; Orenstein D; LaPier T
    Am J Prev Med; 2005 Dec; 29(5 Suppl 1):113-21. PubMed ID: 16389136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-risk appraisal with or without disease management for worksite cardiovascular risk reduction.
    Maron DJ; Forbes BL; Groves JR; Dietrich MS; Sells P; DiGenio AG
    J Cardiovasc Nurs; 2008; 23(6):513-8. PubMed ID: 18953215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol management: guidelines have changed, although diet is still central.
    Stoy DB
    AAOHN J; 1994 Mar; 42(3):102-7. PubMed ID: 8147994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol intervention in the workplace: successful integration with other risk reduction programs.
    Rudd CL
    AAOHN J; 1994 Mar; 42(3):113-6. PubMed ID: 8147996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol education at the worksite.
    O'Brien S; Dedmon RE
    AAOHN J; 1990 May; 38(5):216-21. PubMed ID: 2331250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass media approaches to reducing cardiovascular disease risk.
    Bellicha T; McGrath J
    Public Health Rep; 1990; 105(3):245-52. PubMed ID: 2113682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk factor reduction and the occupational health nurse.
    Russo A; Pryor E; Brown KC; Kinney MR
    AAOHN J; 1990 Sep; 38(9):419-32. PubMed ID: 2204344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Cholesterol Education Program.
    Cleeman JI
    Clin Lab Med; 1989 Mar; 9(1):7-15. PubMed ID: 2647377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risks in firefighters: implications for occupational health nurse practice.
    Byczek L; Walton SM; Conrad KM; Reichelt PA; Samo DG
    AAOHN J; 2004 Feb; 52(2):66-76. PubMed ID: 14979617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in a worksite cholesterol education program in a university setting.
    Greene GW; Strychar I
    J Am Diet Assoc; 1992 Nov; 92(11):1376-81. PubMed ID: 1430724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in reducing cardiovascular risk factors in the United States: focus on worksite health and wellness.
    Cahalin LP; Myers J; Kaminsky L; Briggs P; Forman DE; Patel MJ; Pinkstaff SO; Arena R
    Prog Cardiovasc Dis; 2014; 56(5):476-83. PubMed ID: 24607011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lucent-Takes-Heart cardiovascular health management program. Successful workplace screening.
    Guico-Pabia CJ; Cioffi L; Shoner LG
    AAOHN J; 2002 Aug; 50(8):365-72. PubMed ID: 12227211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for cardiovascular disease in U.S. medical students: the Preventive Cardiology Academic Award Collaborative Data Project.
    Eaton CB; Schaad DC; Rybicki B; Pearson TA; Van Citters RL; Stone EJ; Castle CH; Cohen JD; Davidson DM; Greenland P
    Am J Prev Med; 1990; 6(2 Suppl):14-22. PubMed ID: 2383408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
    Cho SW; Kang JY; Park YK; Paek YM; Choi TI
    Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.